EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.95 | (2,3-dihydro-1H-benzotriazol-1-yl)(4-phenylpiperazin-1-yl)methanone | 0.1 mM, 37% inhibition | Homo sapiens | |
1.1.1.95 | (3,4-dichlorophenyl)(morpholin-4-yl)methanethione | 0.1 mM, 96% inhibition | Homo sapiens | |
1.1.1.95 | 1-(2-bromophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one | - |
Homo sapiens | |
1.1.1.95 | 1-(2-chlorophenyl)-1H-pyrrole-2,5-dione | 0.1 mM, 78% inhibition | Homo sapiens | |
1.1.1.95 | 1-(4-bromophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one | - |
Homo sapiens | |
1.1.1.95 | 1-(4-chlorophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one | - |
Homo sapiens | |
1.1.1.95 | 1-(4-fluorophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one | - |
Homo sapiens | |
1.1.1.95 | 1-(4-iodophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one | - |
Homo sapiens | |
1.1.1.95 | 1-(4-methoxybenzene-1-sulfonyl)piperazine | 0.1 mM, 35% inhibition | Homo sapiens | |
1.1.1.95 | 2-(morpholin-4-yl)-1-(3-nitrophenyl)-2-sulfanylideneethan-1-one | - |
Homo sapiens | |
1.1.1.95 | 2-(morpholin-4-yl)-1-(4-nitrophenyl)-2-sulfanylideneethan-1-one | - |
Homo sapiens | |
1.1.1.95 | 2-(morpholin-4-yl)-1-phenyl-2-sulfanylideneethan-1-one | - |
Homo sapiens | |
1.1.1.95 | 2-phenylmorpholine | 0.1 mM, 61% inhibition | Homo sapiens | |
1.1.1.95 | 3-pentyl-5,5-diphenylimidazolidine-2,4-dione | 0.1 mM, 25% inhibition | Homo sapiens | |
1.1.1.95 | 4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine | 0.1 mM, 46% inhibition | Homo sapiens | |
1.1.1.95 | 4-benzyl-N-[3,5-bis(trifluoromethyl)phenyl]piperazine-1-carbothioamide | 0.1 mM, 80% inhibition | Homo sapiens | |
1.1.1.95 | 4-chloro-N-(2-nitrophenyl)benzamide | 0.1 mM, 59% inhibition | Homo sapiens | |
1.1.1.95 | 4-[(1S)-1-[(5-chloro-6-[2-[(2-hydroxyethyl)amino]-2-oxoethoxy]-1H-indole-2-carbonyl)amino]-2-hydroxyethyl]benzoic acid | competitive, i.e. SPR Kd | Homo sapiens | |
1.1.1.95 | cyclohexa-2,5-diene-1,4-dione | 0.1 mM, 100% inhibition | Homo sapiens | |
1.1.1.95 | ethyl 5-[(furan-2-carbonyl)amino]-3-methyl-4-(nitrilo-lambda4-sulfanyl)thiophene-2-carboxylate | noncompetitive, i.e. CBR-5884 | Homo sapiens | |
1.1.1.95 | N-(4,6-dimethylpyridin-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]piperazine-1-carbothioamide | noncompetitive, i.e. NCT-503 | Homo sapiens | |
1.1.1.95 | N-(4,6-dimethylpyrimidin-2-yl)-4-nitrobenzamide | 0.1 mM, 13% inhibition | Homo sapiens | |
1.1.1.95 | N-(diphenylmethyl)-4-nitrobenzamide | 0.1 mM, 54% inhibition | Homo sapiens | |
1.1.1.95 | N-cyclohexyl-N'-phenylthiourea | 0.1 mM, 28% inhibition | Homo sapiens | |
1.1.1.95 | naphthalene-1,4-dione | 0.1 mM, 95% inhibition | Homo sapiens | |
1.1.1.95 | phenyl cyclohexylcarbamodithioate | 0.1 mM, 51% inhibition | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.95 | 3-phospho-D-glycerate + NAD+ | Homo sapiens | - |
3-phosphooxypyruvate + NADH + H+ | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.95 | Homo sapiens | O43175 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.95 | 3-phospho-D-glycerate + NAD+ | - |
Homo sapiens | 3-phosphooxypyruvate + NADH + H+ | - |
r |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.1.95 | Phgdh | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.95 | NAD+ | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.1.1.95 | 0.00987 | - |
pH 8.8, 25°C | Homo sapiens | 1-(4-chlorophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one | |
1.1.1.95 | 0.016 | - |
pH 8.8, 25°C | Homo sapiens | (3,4-dichlorophenyl)(morpholin-4-yl)methanethione | |
1.1.1.95 | 0.0309 | - |
pH 8.8, 25°C | Homo sapiens | 2-(morpholin-4-yl)-1-phenyl-2-sulfanylideneethan-1-one | |
1.1.1.95 | 0.0351 | - |
pH 8.8, 25°C | Homo sapiens | 2-(morpholin-4-yl)-1-(4-nitrophenyl)-2-sulfanylideneethan-1-one | |
1.1.1.95 | 0.0689 | - |
pH 8.8, 25°C | Homo sapiens | 1-(4-fluorophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one | |
1.1.1.95 | 0.0752 | - |
pH 8.8, 25°C | Homo sapiens | 4-chloro-N-(2-nitrophenyl)benzamide | |
1.1.1.95 | 0.0881 | - |
pH 8.8, 25°C | Homo sapiens | 2-(morpholin-4-yl)-1-(3-nitrophenyl)-2-sulfanylideneethan-1-one | |
1.1.1.95 | 0.1307 | - |
pH 8.8, 25°C | Homo sapiens | 1-(4-bromophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one | |
1.1.1.95 | 0.1607 | - |
pH 8.8, 25°C | Homo sapiens | 1-(2-bromophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one | |
1.1.1.95 | 0.1777 | - |
pH 8.8, 25°C | Homo sapiens | 1-(4-iodophenyl)-2-(morpholin-4-yl)-2-sulfanylideneethan-1-one |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.1.1.95 | drug target | the enzyme is an attractive drug target in tumors that overexpress PHGDH or amplify the PHGDH gene | Homo sapiens |